Category: 2023 Watch List

Featured

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

Editor | Curator - April 16, 2026

TESTIMONIALS

$400 Million Man Tries Psychedelic Toads.

Editor | Curator - March 24, 2026

Featured

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Editor | Curator - June 24, 2025

Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?

2023 Watch List Editor | Curator - April 24, 2023

After Dropping 94% From Post IPO high from $19.45, a loss of exceeding $3 billion and change, ATAI is in the early stages of a recovery (our opinion) gaining 94%...

View Post

Silo Pharma (SILO) Issues Letter to Shareholders

2023 Watch List Editor | Curator - December 2, 2022

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE QUOTE Bargain Hunters Dream

View Post

Mystery Solved. Threshold Bioscience’s Neuroblo-Ibogaine!

Featured Editor | Curator - April 16, 2026

500mg Iboga Total Alkaloid (TA) Extract. Someone posted this photo on LinkedIn, which we took as a tease....

$400 Million Man Tries Psychedelic Toads.

TESTIMONIALS Editor | Curator - March 24, 2026

"This was the most profound experience of my life. I am stunned beyond comprehension. This molecule is without peer."

Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36

Featured Editor | Curator - June 24, 2025

The Montgomery-Asberg Depression Rating Scale. We were flying from Hawaii to Las Vegas yesterday and when we landed,...